ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.053 AUD -1.85% Market Closed
Market Cap: 107.2m AUD
Have any thoughts about
ImpediMed Ltd?
Write Note

ImpediMed Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

ImpediMed Ltd
Revenue Peer Comparison

Comparables:
R
RSH
C
CYC
COH
OIL
EMV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
ImpediMed Ltd
ASX:IPD
Revenue
AU$10.3m
CAGR 3-Years
7%
CAGR 5-Years
20%
CAGR 10-Years
11%
R
Respiri Ltd
ASX:RSH
Revenue
AU$1m
CAGR 3-Years
-10%
CAGR 5-Years
0%
CAGR 10-Years
14%
C
Cyclopharm Ltd
ASX:CYC
Revenue
AU$29m
CAGR 3-Years
19%
CAGR 5-Years
16%
CAGR 10-Years
8%
Cochlear Ltd
ASX:COH
Revenue
AU$2.2B
CAGR 3-Years
14%
CAGR 5-Years
9%
CAGR 10-Years
11%
Optiscan Imaging Ltd
ASX:OIL
Revenue
AU$1.2m
CAGR 3-Years
9%
CAGR 5-Years
2%
CAGR 10-Years
29%
EMvision Medical Devices Ltd
ASX:EMV
Revenue
AU$11.6m
CAGR 3-Years
182%
CAGR 5-Years
59%
CAGR 10-Years
N/A

See Also

What is ImpediMed Ltd's Revenue?
Revenue
10.3m AUD

Based on the financial report for Jun 30, 2024, ImpediMed Ltd's Revenue amounts to 10.3m AUD.

What is ImpediMed Ltd's Revenue growth rate?
Revenue CAGR 10Y
11%

Over the last year, the Revenue growth was -9%. The average annual Revenue growth rates for ImpediMed Ltd have been 7% over the past three years , 20% over the past five years , and 11% over the past ten years .

Back to Top